NCT01073917

Brief Summary

Atelectasis and redistribution of ventilation towards non-dependent lung zones are a common side effects of general anesthesia. Spontaneous breathing activity (SBA) during mechanical ventilation may avoid or reduce atelectasis, improving arterial oxygenation; however, it is unclear whether these effects play a significant role during general anesthesia in patients with healthy lungs. Earlier studies on ventilation during general anesthesia had to rely on computed tomography (CT) findings. Recent advances in lung imaging technology allow to assess the regional aeration of the lungs continuously and non-invasive by electrical impedance technology (EIT). In this work, we will use the EIT to assess ventilation changes from the time before induction of anesthesia until discharge from the post-anesthesia care unit. Our main focus is the difference caused by pure positive pressure ventilation (PCV) and assisted spontaneous breathing (pressure support ventilation, PSV). Our findings would improve our understanding of the physiology of the lungs during general anesthesia and would help to improve the standards of respiratory care during anesthesia

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 22, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 23, 2010

Completed
6 days until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

October 29, 2010

Status Verified

October 1, 2010

Enrollment Period

7 months

First QC Date

February 22, 2010

Last Update Submit

October 28, 2010

Conditions

Keywords

VentilationGeneral Anesthesiaelectrical impedance tomographypressure supportspontaneous breathinglaryngeal maskPatients who are scheduled for elective knee or ankle surgery

Outcome Measures

Primary Outcomes (1)

  • Regional ventilation at the end of anaesthesia and at discharge from PACU compared to baseline values obtained before induction

    Before, during and after anesthesia

Secondary Outcomes (1)

  • Differences in spirometry values, oxygenation in the PACU (measured as SpO2 at room air), breathing effort

    Before, during and after anesthesia

Study Arms (3)

Spontaneous Breathing

OTHER

Patients will be breathing spontaneously during anesthesia

Other: Spontaneous Breathing

Pressure controlled ventilation

OTHER

Patients in the PPV group will be ventilated by pressure control (tidal volume 8-10 ml/kg, frequency 10-14, I:E 1:1, no PEEP, target CO2 4.5 kPa).

Other: Pressure Controlled Ventilation

Pressure Support Ventilation

OTHER

The patients in the PSV group will breathing spontaneously on the ventilator with assistance by inspiratory support pressure. The support pressure will be adjusted to achieve a tidal volume of 8-10 ml/kg.

Other: Pressure Support Ventilation

Interventions

Spontaneous Breathing
Pressure controlled ventilation
Pressure Support Ventilation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients (age 18-65) scheduled for elective knee or ankle surgery under general anaesthesia with an LMA with an expected duration of at least 60 minutes.

You may not qualify if:

  • Pregnancy,
  • Pulmonary diseases (e.g. Asthma, COPD),
  • Implanted pacemaker or AICD,
  • Inability to communicate or understand the risks of the study,
  • Contraindications for an LMA (e.g. obesity, reflux),
  • Deformities of the thorax,
  • Failure to place an LMA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Carl-Gustav-Carus

Dresden, Saxony, 01307, Germany

Location

Related Links

MeSH Terms

Conditions

Pulmonary AtelectasisRespiratory Aspiration

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 22, 2010

First Posted

February 23, 2010

Study Start

March 1, 2010

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

October 29, 2010

Record last verified: 2010-10

Locations